An observational study to evaluate the use of Souvenaid in real world daily clinical practice in patients with early Alzheimer’s Disease.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON26650

Enrollment

315

Registered

2013-02-13

Start date

2013-02-20

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early Alzheimer's Disease Souvenaid daily clinical practice IADL

Interventions

1 Souvenaid per day.

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patient is diagnosed with early AD as judged by the HCP (based on criteria used in the memory clinic); 2. The patient has a MMSE score of >20; 3. The HCP has decided to prescribe Souvenaid (up to 1 month ago); 4. A responsible caregiver of the patient is available; 5. The patient and caregiver are willing to give written approval of collecting anonymous data.

Exclusion criteria

Exclusion criteria: 1. The patient participates in any other study involving investigational or marketed products concomitantly or has participated in such a study within two weeks prior to entry into the study; 2. HCP’s uncertainty about medical status, willingness or ability of the patient to comply with protocol requirements.

Design outcomes

Primary

Measure	Time frame
IADL (Amsterdam IADL Questionnaire).	—

Secondary

Measure	Time frame
Compliance.	—

Contacts

Public ContactKarina Roozen

Nutricia Advanced Medical Nutrition Postbus 445

karina.roozen@nutricia.com+31 (0)6 55860755

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)